Abstract:Objective To evaluate the value of transrectal ultrasound-guided systematic prostate biopsy and magnetic resonance imaging(MRI) suspicious targeted biopsy in the biopsy of prostate cancer.Methods A retrospective analysis was performed in 181 patients with suspected prostate cancer underwent transrectal ultrasound-guided prostate biopsy from September 2011 to September 2013 in the Second Affiliated Hospital of Zhejiang University School of Medicine.In all the 181 patients had the transrectal ultrasound-guided systematic biopsy,116 patients with suspicious MRI had two additional targeted biopsies.Prostate cancers were detected in 97 of 181 patients,and the prostatic hyperplasia were detected in 84 patients.The detection rate of transrectal ultrasound-guided systematic prostate biopsy,suspicious MRI targeted biopsy and combined biopsy in prostate cancer were tested by χ2 test.Compared with pathological results,the sensitivity,specificity,accuracy,positive predictive value and negative predictive value of transrectal ultrasound-guided systematic prostate biopsy and suspicious MRI targeted biopsy were calculated and tested by χ2 test.Results Prostate cancer was detected in 97 of 181 patients(53.6%),63(34.8%) was detected by transrectal ultrasound-guided systematic prostate biopsy,and 81(44.8%) was detected by suspicious MRI targeted biopsy.The suspicious MRI targeted biopsy detected more prostate cancers which there had statistical differences compared with transrectal ultrasound-guided systematic prostate biopsy(χ2=34.830,P=0.015).Transrectal ultrasound guided prostate systematic biopsy missed 34 cases of prostate cancer,and suspicious MRI targeted biopsy missed 16 cases,accounting for 35.1%(34/97) and 16.5%(16/97) of prostate cancer.The 181 patients were biopsied a total of 1 896 cores,including transrectal ultrasound guided systematic biopsy 1 448 cores and suspicious MRI targeted biopsy 448 cores.The sensitivity,specifi city,positive predictive value and negative predictive value of suspicious MRI targeted biopsy was 89.8%(280/312),87.4%(1 384/1 584),58.3%(280/480),97.7%(1 384/1 416) compared with the sensitivity of 71.8%(224/312),specifi city of 22.7%(360/1 584),positive predictive value of 15.5%(224/1 448) and negative predictive value of 80.4%(360/448) in transrectal ultrasound-guided systematic prostate biopsy(χ2=14.008,96.037,143.049,170.729,all P < 0.001).Conclusions The detection rate of prostate cancer of suspicious MRI targeted biopsy is higher than transrectal ultrasound-guided systematic prostate biopsy,but can′t replace transrectal ultrasound-guided systematic prostate biopsy.The two methods are complementary to improve the prostate cancer detection rate.

Role of Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Targeted Biopsy in the Detection of Prostate Cancer in Biopsy-Naïve Men: A Literature Based Meta-Analysis of Randomized Trials.

The value of transrectal ultrasound-guided systematic prostate biopsy and additional targeted cores from suspicious magnetic resonance imaging in the biopsy of prostate cancer

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

Injection of Autologous Muscle Stem Cells (Myoblasts) for the Treatment of Vocal Fold Paralysis: A Pilot Study

Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis

Assessment of Free-Hand Transperineal Targeted Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion in Chinese Men with Prior Negative Biopsy and Elevated Prostate-Specific Antigen

Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors.

Effectiveness and Accuracy of MRI‐Ultrasound Fusion Targeted Biopsy Based on PI‐RADS v2.1 Category in Transition/Peripheral Zone of the Prostate

Magnetic Resonance Imaging - Ultrasound Fusion Targeted Biopsy Outperforms Standard Approaches in Detecting Prostate Cancer: A Meta-Analysis.

Comparison of transperineal and transrectal biopsy approaches to detect clinically significant prostate cancer in patients undergoing MRI fusion prostate biopsy: A lesion level analysis.

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis

Combined MRI-TRUS fusion targeted and systematic biopsy versus systematic biopsy alone for the detection of prostate cancer: protocol for a prospective single-centre trial

[The electroencephalogram after acute heart arrest].

Magnetic Resonance Imaging-Directed Biopsy Improves The Prediction Of Prostate Cancer Aggressiveness Compared With A 12-Core Transrectal Ultrasound-Guided Prostate Biopsy

Permissible Intraabdominal Hypertension following Complex Abdominal Wall Reconstruction

MRI/US imaging fusion guided transperineal prostate biopsy:a research in single center

Cognitive magnetic resonance imaging-ultrasound fusion transperineal targeted biopsy combined with randomized biopsy in detection of prostate cancer

Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center

Free-hand Transperineal Multiparametric Magnetic Resonance Imaging/transrectal Ultrasound Fusion-Guided Targeted Biopsy for the Diagnosis of Prostate Cancer: a Prospective Study

Motility, cell shape, and locomotion of neutrophil granulocytes.

Comparison of MRI Artificial Intelligence-Guided Cognitive Fusion-Targeted Biopsy Versus Routine Cognitive Fusion-Targeted Prostate Biopsy in Prostate Cancer Diagnosis: a Randomized Controlled Trial